Long noncoding RNA PANDAR promotes progression and predicts poor prognosis via upregulating ROCK1 in prostate cancer
J. Yang, S. Zhao, B. Li Department of Pathology, Jinzhou Medical University, Jinzhou, China.
Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, “Long noncoding RNA PANDAR promotes progression and predicts poor prognosis via upregulating ROCK1 in prostate cancer, by J. Yang, S. Zhao, B. Li, published in Eur Rev Med Pharmacol Sci 2019; 23 (11): 4706-4712–DOI: 10.26355/eurrev_201906_18051–PMID: 31210296” has been withdrawn.
The Publisher apologizes for any inconvenience this may cause.
Free PDF Download
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
J. Yang, S. Zhao, B. Li
Long noncoding RNA PANDAR promotes progression and predicts poor prognosis via upregulating ROCK1 in prostate cancer
Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 22
Pages: 11466-11466
DOI: 10.26355/eurrev_202011_23755